The global “Oncology Drugs Market” is expected to reach USD 394.24 billion by 2027, exhibiting a CAGR of 11.6% during the forecast period. The growing prevalence of cancer around the world will spur opportunities for this market during the forecast period, states Fortune Business Insights, in a report, titled “Oncology Drugs Market Size, Share &COVID-19 Impact Analysis, By Drugs Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, and Others), By Therapy (Chemotherapy, Targeted Therapy, and Immunotherapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, and Others), By Dosage Form (Solid, Liquid, and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), and Regional Forecast, 2020-2027.” The market size stood at USD 141.33 billion in 2019.

Major Oncology Drugs Market Key players covered in the report include:

  • Merck & Co.
  • Sanofi
  • GlaxoSmithKline
  • AbbVie
  • Takeda Oncology Drugs Ltd.
  • AstraZeneca
  • Pfizer, Inc.
  • Novartis AG
  • Hoffmann-La Roche Ltd.
  • Johnson & Johnson Services Inc.

Get Request a Sample Copy of the Oncology Drugs Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/oncology-drugs-market-103431

Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for market to figure out and study the market’s needs, market size, and competition.

Oncology Drugs Market Analysis 2021:

Regional Analysis:

Rising Prevalence to Cancer to Influence Market in North America

The market size in North America is expected to witness a rapid growth rate during the forecast period. The dominance in the region is attributed to the growing prevalence of cancer in the U.S. As per the National Cancer Institute, in 2020, approximately 1.8 million people will be diagnosed with cancer in the U.S. The recent product launches will aid the expansion of the market in the region. Europe is predicted to exhibit a stellar growth rate during the forecast period owing to the growing cancer burden in countries such as U.K., Germany, and France. The market in Asia Pacific is predicted to rise tremendously during the forecast period due to the rising awareness among the population regarding cancer.

Market Driver:

Surging Pharmaceutical Industry to Contribute Colossal Development

The ongoing technological advancement in the field of pharmacy is expected to create opportunities for the market during the forecast period. The clinical trials and various drugs in the pipeline can further facilitate the healthy growth of the industry. The growing cases of numerous types of cancer, such as lung cancer, skin cancer, prostate cancer, colon cancer, breast cancer, and others will spur demand for oncology drugs, thus enhancing market growth. According to the World Health Organization (WHO), cancer is a growing burden and the number of new cancer cases is going to rise from 18.1 million in 2018 to 29.4 million by 2040. Moreover, product launches and approvals are expected to have a tremendous impact on the market.

Positive Impact on Oncology Drugs Market Growth During COVID-19

The outbreak of COVID-19 has had a positive impact on the oncology drugs market globally. Certain market segments have witnessed a growth in demand for drugs with respect to the COVID-19 emergency. Panic buying of medications has been witnessed among the cancer patients amid lockdown. The pharmaceutical companies involved in this market have significantly improved their supply chain management, enhanced the capabilities of their R&D, and invested more their manufacturing management and quality control. For instance, according to the quarterly reports of 2020 of Roche, their global supply chain of medicines and tests remain intact and their pharmaceutical division sales increased by 7% as compared to the prior year.

Key Development:

April 2019: Sun Pharmaceutical Industries announced the release of INFUGEM injection, which will ve used for the treatment of cancer in the US.

Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/oncology-drugs-market-103431

Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Key Indications (Lung Cancer, Breast Cancer, Prostate Cancer, etc.), By Region/Country
    • Overview of Different Oncology Drugs with respect to Regulatory Approvals and Clinical Trials
    • Pricing Analysis, By Key Players
    • Recent Advancements in Development of Oncology Drugs
    • Key Industry Developments (Mergers, Acquisitions, and Partnerships)
    • Impact of COVID-19 on Oncology Drugs Market
  • Global Oncology Drugs Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Cytotoxic Drugs
        • Alkylating Agents
        • Antimetabolites
        • Others
      • Targeted Drugs
        • Monoclonal Antibodies
        • Others
      • Hormonal Drugs
      • Others
    • Market Analysis, Insights and Forecast – By Therapy
      • Chemotherapy
      • Targeted Therapy
      • Immunotherapy
    • Market Analysis, Insights and Forecast – By Indication
      • Lung Cancer
      • Stomach Cancer
      • Colorectal Cancer
      • Breast Cancer
      • Prostate Cancer
      • Others
    • Market Analysis, Insights and Forecast – By Dosage Form
      • Solid
        • Tablets
        • Capsules
      • Liquid
      • Injectable
        • Prefilled Syringes
        • Others
      • Market Analysis, Insights and Forecast- By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Others
      • Market Analysis, Insights and Forecast – By Region
        • North America
        • Europe
        • Asia Pacific
        • Latin America
        • Middle East & Africa
      • North America Oncology Drugs Market Analysis, Insights and Forecast, 2016-2027
        • Key Findings / Summary
        • Market Analysis – By Drug Class
          • Cytotoxic Drugs
            • Alkylating Agents
            • Antimetabolites
            • Others
          • Targeted Drugs
            • Monoclonal Antibodies
            • Others
          • Hormonal Drugs
          • Others
        • Market Analysis – By Therapy
          • Chemotherapy
          • Targeted Therapy
          • Immunotherapy
        • Market Analysis – By Indication
          • Lung Cancer
          • Stomach Cancer
          • Colorectal Cancer
          • Breast Cancer
          • Prostate Cancer
          • Others
        • Market Analysis – By Dosage Form
          • Solid
            • Tablets
            • Capsules
          • Liquid
          • Injectable
            • Prefilled Syringes
            • Others
          • Market Analysis – By Country
            • U.S.
            • Canada

Toc Continue…

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune -411045, Maharashtra, India.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

 

Related Reports :

Digital Therapeutics Market

Digital Therapeutics Market Size

Digital Therapeutics Market Share

Digital Therapeutics Market Trends

Digital Therapeutics Market Growth

Hysteroscope Market Analysis

Hysteroscope Market Business Opportunities

Hysteroscope Market Key Players

Hysteroscope Market Demand

Hysteroscope Market Competitive Landscape

Leave a Reply

Your email address will not be published. Required fields are marked *